Cargando…
TRAIL Receptor Signaling Regulation of Chemosensitivity In Vivo but Not In Vitro
BACKGROUND: Signaling by Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) and Fas ligand (FasL) has been proposed to contribute to the chemosensitivity of tumor cells treated with various other anti-cancer agents. However, the importance of these effects and whether there are differen...
Autores principales: | Menke, Christina, Goncharov, Tatiana, Qamar, Lubna, Korch, Christopher, Ford, Heide L., Behbakht, Kian, Thorburn, Andrew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021504/ https://www.ncbi.nlm.nih.gov/pubmed/21264287 http://dx.doi.org/10.1371/journal.pone.0014527 |
Ejemplares similares
-
Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo
por: Wang, Lei, et al.
Publicado: (2014) -
In vitro and in vivo evaluation of didymin cyclodextrin inclusion complexes: characterization and chemosensitization activity
por: Yao, Qing, et al.
Publicado: (2019) -
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
por: Wheeler, Lindsay J., et al.
Publicado: (2018) -
Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling
por: Oh, You-Take, et al.
Publicado: (2021) -
TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis
por: López-Gómez, Carlos, et al.
Publicado: (2011)